Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03070873
Other study ID # NMU-201666
Secondary ID
Status Completed
Phase N/A
First received February 15, 2017
Last updated February 28, 2017
Start date January 1, 2010
Est. completion date January 30, 2014

Study information

Verified date February 2017
Source Nanjing Medical University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The investigators designed a prospective study in this article to evaluate the efficacy, the life quality and the complications of two different meshes of type I (one is Perigee/Apogee, the other is named Gynecare prolift) versus traditional surgery, and also studied the influence of some surgical procedures on the prognosis.


Description:

Pelvic organ prolapse is defined as a downward descent of the pelvic organs that results in the protrusion of vagina, uterus, or both. The investigators designed a prospective study in this article to evaluate the efficacy, the life quality and the complications of two different meshes of type I (one is Perigee/Apogee, the other is named Gynecare prolift) versus traditional surgery. The investigators also studied the influence of some surgical procedures on the prognosis. In this study,The investigators divided the patients randomly into three groups :the group A was a total of 91 patients who accepted transvaginal hysterectomy and total pelvic floor reconstruction combined Perigee and Apogee polypropylene mesh(PA);the group B was a total of 97 patients who accepted transvaginal hysterectomy and total pelvic floor reconstruction with Gynecare prolift polypropylene mesh;the group C was a total of 70 patients who accepted transvaginal hysterectomy and anterior and posterior vaginal wall repair without any mesh.The investigators did POP-Q measurements and questionnaire preoperatively and postoperatively and recorded volume of bleeding,day of postoperative indwelling catheter and the mesh complications。


Recruitment information / eligibility

Status Completed
Enrollment 258
Est. completion date January 30, 2014
Est. primary completion date January 30, 2014
Accepts healthy volunteers No
Gender Female
Age group 50 Years to 85 Years
Eligibility Inclusion Criteria:

- Patients with stage III ~ IV degree of anterior and posterior vaginal wall prolapse and uterine prolapse (total pelvic floor prolapse) by the Pelvic Organ Prolapse Quantification System (POP-Q) were included

Exclusion Criteria:

- Simple anterior or posterior wall prolapse, simple uterine prolapse, combined with stress urinary incontinence, overactive bladder (OAB), pelvic floor repair surgery history and recurrent patients

- Local or systemic conditions that would preclude surgery or affect healing such as restricted leg motion (inability to conform to the lithotomy position)

- Vaginal bleeding;coagulation disorders

- Infection,or uncontrolled hypertension and diabetes mellitus

- Pelvic cancer and radiation to the pelvic area in the previous 6 months.

- Also women of reproductive age, and planning of pregnancy were also excluded for mesh usage.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Perigee and Apogee Mesh
The investigators divided the patients randomly into three groups :the group A received Perigee and Apogee polypropylene mesh(PA);the group B received Gynecare prolift polypropylene mesh;the group C was without any mesh.
Gynecare Prolift Mesh
The investigators divided the patients randomly into three groups :the group A received Perigee and Apogee polypropylene mesh(PA);the group B received Gynecare prolift polypropylene mesh;the group C was without any mesh.
Procedure:
Traditional Surgery
The investigators divided the patients randomly into three groups :the group A received Perigee and Apogee polypropylene mesh(PA);the group B received Gynecare prolift polypropylene mesh;the group C was without any mesh.

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Nanjing Medical University

Outcome

Type Measure Description Time frame Safety issue
Primary Pelvic Organ Prolapse Quantification the prolapse of stage II and above is defined as recurrence in POP-Q stage. at 12 months after surgery
Primary sexual quality of life through the pelvic organ prolapse / urinary incontinence sexual questionnaire PISQ-12 at 12 months after surgery
Primary pelvic floor distress inventory short form PFDI-20 at 12 months after surgery
Primary mesh exposure mesh was seen in the vagina by gynecological examination at 12 months after surgery
Primary sexual quality of life through the pelvic organ prolapse / urinary incontinence sexual questionnaire PISQ-12 at 24 months after surgery
Primary Pelvic Organ Prolapse Quantification the prolapse of stage II and above is defined as recurrence in POP-Q stage. at 24 months after surgery
Primary pelvic floor distress inventory short form PFDI-20 at 24 months after surgery
Primary mesh exposure mesh was seen in the vagina by gynecological examination at 24 months after surgery
Primary sexual quality of life through the pelvic organ prolapse / urinary incontinence sexual questionnaire PISQ-12 baseline
Primary pelvic floor distress inventory short form PFDI-20 baseline
Secondary stress urinary incontinence leakage of urine with exertion or with sneezing or coughing at 1 months after surgery
Secondary stress urinary incontinence leakage of urine with exertion or with sneezing or coughing 3 months after surgery
Secondary Volume of bleeding during the operation
Secondary Elevated blood pressure during the operation
Secondary Day of postoperative indwelling catheter 1 months after surgery
Secondary Number of constipation 1 months after surgery
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05422209 - The Influence of Simultaneous Posterior Colporrhaphy and Perineoplasty on the Efficiency and Safety of Mesh-augmented Sacrospinal Fixation (Apical Sling) in Advanced POP Repair. N/A
Active, not recruiting NCT05420831 - Comparison of Vaginal and Laparoscopic Apical Fixation Techniques for Pelvic Organ Prolapse Treatment N/A
Completed NCT05493735 - Lidocaine for Pessary Check Pain Reduction Phase 3
Completed NCT06126328 - Materna Prep Study Phase II Phase 2
Recruiting NCT05542836 - EVeRLAST 2-Year Follow-Up
Recruiting NCT05918367 - Multicenter Ventral Mesh Rectopexy Registry Collaborative
Recruiting NCT04172272 - The Influence of TAP Block in the Control of Postoperative Pain After Laparotomy for Gynecological Procedures N/A
Recruiting NCT04807920 - BOTOX® at the Time of Prolapse Surgery for OAB Phase 4
Completed NCT06268782 - The Effectiveness of an Online Exercise Program on Well-being of Postpartum Women N/A
Recruiting NCT02919852 - Laparoscopic Retrovesical Colpopectinopexia N/A
Recruiting NCT03146195 - The 3D Reconstruction Research of Pelvic Organ Prolapse Disease N/A
Completed NCT02925585 - Vaginal Tactile Imaging for Pelvic Floor Prolapse
Not yet recruiting NCT02536001 - Prospective Randomized Study to Compare Results of Pelvic Organ Prolapse Repair With One Versus Two Vaginal Meshes N/A
Recruiting NCT02113969 - Conservative Management of Symptomatic Pelvic Organ Prolapse Using Vaginal Pessaries: Generation of a Standardized Management Protocol N/A
Completed NCT02383199 - Polypropylene Mesh in Prolapse Surgery N/A
Terminated NCT01673360 - Collection of Long Term Patient Outcomes Data Following Implantation of AMS Surgical Devices N/A
Withdrawn NCT01530191 - Factors Affecting Perioperative Outcomes N/A
Completed NCT01842464 - Sacro-Spinous Ligaments Anterior Apical Anchoring N/A
Completed NCT01320631 - Male Sexual Experience and Its Impact on Quality of Life Before and After Their Sexual Partners Undergo Polypropylene Mesh Augmented Pelvic Floor Reconstruction N/A
Completed NCT00581412 - Composite Graft Use in Abdominal Sacrocolpopexy Reduces Erosion Rates N/A